News
11-09-2010, 03:14 AM
A new study suggests joint complaints attributed to aromatase inhibitors (AI), popular breast cancer drugs, are not associated with inflammatory arthritis or autoimmune disease. Because of that, researchers say women who were primarily concerned about the threat of arthritis should be encouraged to continue taking the medication. The findings of the study will be presented Tuesday, Nov. 9 at the 74th Annual Scientific Meeting of the American College of Rheumatology in Atlanta, Georgia
More... (http://www.news-medical.net/news/20101109/Joint-complaints-attributed-to-breast-cancer-drugs-not-linked-with-inflammatory-arthritis-or-autoimmune-disease.aspx)
More... (http://www.news-medical.net/news/20101109/Joint-complaints-attributed-to-breast-cancer-drugs-not-linked-with-inflammatory-arthritis-or-autoimmune-disease.aspx)